Desire for information and involvement in treatment decisions

Lung cancer patients' preferences and their physicians' perceptions: Results from Okayama Lung Cancer Study Group trial 0705

Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Hiroshige Yoshioka, Hidetoshi Hayashi, Hajime Fukuyama, Akihiro Nishiyama, Toshihide Yokoyama, Shoichi Kuyama, Shigeki Umemura, Yuka Kato, Naoyuki Nogami, Yoshihiko Segawa, Masayuki Yasugi, Masahiro Tabata, Mitsune Tanimoto

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Introduction: This study explores patient preferences for involvement in lung cancer treatment decisions and the extent of concordance between the views of patients and physicians on decisional roles. The impact of demographic and psychosocial characteristics on the decisional role of patients is also examined. Methods: Patients with relapsed non-small cell lung cancer who were candidates for a phase II trial of erlotinib monotherapy were recruited. Patients were interviewed after they had learned of their relapse and the treatment decision had been made but before pharmacologic intervention. Results: Most of the 28 participants were married, had a smoking history, and were well educated. They reported moderate levels of depression and anxiety. Initially, 14% of the patients reported a preference for active decision making; later, 29% believed that the primary responsibility for the treatment decision had been theirs. Only 54% of the patients agreed with the physician's assessment of how the treatment decision was made (κ = 0.31; test of symmetry, p = 0.23). The depression score was significantly associated with a patient's preferred level of control (p <0.01). Conclusions: The limited concordance between patient preference and perception and between patient and physician perceptions regarding how the treatment decision was made suggests that physicians should more accurately identify patient preferences by directly asking patients at the beginning of each clinical encounter.

Original languageEnglish
Pages (from-to)1668-1672
Number of pages5
JournalJournal of Thoracic Oncology
Volume5
Issue number10
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Patient Preference
Lung Neoplasms
Physicians
Therapeutics
Depression
Non-Small Cell Lung Carcinoma
Decision Making
Anxiety
Smoking
History
Demography
Recurrence

Keywords

  • Decisional role
  • Non-small cell lung cancer
  • Perception
  • Preference

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Desire for information and involvement in treatment decisions : Lung cancer patients' preferences and their physicians' perceptions: Results from Okayama Lung Cancer Study Group trial 0705. / Hotta, Katsuyuki; Kiura, Katsuyuki; Takigawa, Nagio; Yoshioka, Hiroshige; Hayashi, Hidetoshi; Fukuyama, Hajime; Nishiyama, Akihiro; Yokoyama, Toshihide; Kuyama, Shoichi; Umemura, Shigeki; Kato, Yuka; Nogami, Naoyuki; Segawa, Yoshihiko; Yasugi, Masayuki; Tabata, Masahiro; Tanimoto, Mitsune.

In: Journal of Thoracic Oncology, Vol. 5, No. 10, 10.2010, p. 1668-1672.

Research output: Contribution to journalArticle

Hotta, K, Kiura, K, Takigawa, N, Yoshioka, H, Hayashi, H, Fukuyama, H, Nishiyama, A, Yokoyama, T, Kuyama, S, Umemura, S, Kato, Y, Nogami, N, Segawa, Y, Yasugi, M, Tabata, M & Tanimoto, M 2010, 'Desire for information and involvement in treatment decisions: Lung cancer patients' preferences and their physicians' perceptions: Results from Okayama Lung Cancer Study Group trial 0705', Journal of Thoracic Oncology, vol. 5, no. 10, pp. 1668-1672. https://doi.org/10.1097/JTO.0b013e3181f1c8cb
Hotta, Katsuyuki ; Kiura, Katsuyuki ; Takigawa, Nagio ; Yoshioka, Hiroshige ; Hayashi, Hidetoshi ; Fukuyama, Hajime ; Nishiyama, Akihiro ; Yokoyama, Toshihide ; Kuyama, Shoichi ; Umemura, Shigeki ; Kato, Yuka ; Nogami, Naoyuki ; Segawa, Yoshihiko ; Yasugi, Masayuki ; Tabata, Masahiro ; Tanimoto, Mitsune. / Desire for information and involvement in treatment decisions : Lung cancer patients' preferences and their physicians' perceptions: Results from Okayama Lung Cancer Study Group trial 0705. In: Journal of Thoracic Oncology. 2010 ; Vol. 5, No. 10. pp. 1668-1672.
@article{f0d6cee1333c4a489c505d2a247e96b6,
title = "Desire for information and involvement in treatment decisions: Lung cancer patients' preferences and their physicians' perceptions: Results from Okayama Lung Cancer Study Group trial 0705",
abstract = "Introduction: This study explores patient preferences for involvement in lung cancer treatment decisions and the extent of concordance between the views of patients and physicians on decisional roles. The impact of demographic and psychosocial characteristics on the decisional role of patients is also examined. Methods: Patients with relapsed non-small cell lung cancer who were candidates for a phase II trial of erlotinib monotherapy were recruited. Patients were interviewed after they had learned of their relapse and the treatment decision had been made but before pharmacologic intervention. Results: Most of the 28 participants were married, had a smoking history, and were well educated. They reported moderate levels of depression and anxiety. Initially, 14{\%} of the patients reported a preference for active decision making; later, 29{\%} believed that the primary responsibility for the treatment decision had been theirs. Only 54{\%} of the patients agreed with the physician's assessment of how the treatment decision was made (κ = 0.31; test of symmetry, p = 0.23). The depression score was significantly associated with a patient's preferred level of control (p <0.01). Conclusions: The limited concordance between patient preference and perception and between patient and physician perceptions regarding how the treatment decision was made suggests that physicians should more accurately identify patient preferences by directly asking patients at the beginning of each clinical encounter.",
keywords = "Decisional role, Non-small cell lung cancer, Perception, Preference",
author = "Katsuyuki Hotta and Katsuyuki Kiura and Nagio Takigawa and Hiroshige Yoshioka and Hidetoshi Hayashi and Hajime Fukuyama and Akihiro Nishiyama and Toshihide Yokoyama and Shoichi Kuyama and Shigeki Umemura and Yuka Kato and Naoyuki Nogami and Yoshihiko Segawa and Masayuki Yasugi and Masahiro Tabata and Mitsune Tanimoto",
year = "2010",
month = "10",
doi = "10.1097/JTO.0b013e3181f1c8cb",
language = "English",
volume = "5",
pages = "1668--1672",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "10",

}

TY - JOUR

T1 - Desire for information and involvement in treatment decisions

T2 - Lung cancer patients' preferences and their physicians' perceptions: Results from Okayama Lung Cancer Study Group trial 0705

AU - Hotta, Katsuyuki

AU - Kiura, Katsuyuki

AU - Takigawa, Nagio

AU - Yoshioka, Hiroshige

AU - Hayashi, Hidetoshi

AU - Fukuyama, Hajime

AU - Nishiyama, Akihiro

AU - Yokoyama, Toshihide

AU - Kuyama, Shoichi

AU - Umemura, Shigeki

AU - Kato, Yuka

AU - Nogami, Naoyuki

AU - Segawa, Yoshihiko

AU - Yasugi, Masayuki

AU - Tabata, Masahiro

AU - Tanimoto, Mitsune

PY - 2010/10

Y1 - 2010/10

N2 - Introduction: This study explores patient preferences for involvement in lung cancer treatment decisions and the extent of concordance between the views of patients and physicians on decisional roles. The impact of demographic and psychosocial characteristics on the decisional role of patients is also examined. Methods: Patients with relapsed non-small cell lung cancer who were candidates for a phase II trial of erlotinib monotherapy were recruited. Patients were interviewed after they had learned of their relapse and the treatment decision had been made but before pharmacologic intervention. Results: Most of the 28 participants were married, had a smoking history, and were well educated. They reported moderate levels of depression and anxiety. Initially, 14% of the patients reported a preference for active decision making; later, 29% believed that the primary responsibility for the treatment decision had been theirs. Only 54% of the patients agreed with the physician's assessment of how the treatment decision was made (κ = 0.31; test of symmetry, p = 0.23). The depression score was significantly associated with a patient's preferred level of control (p <0.01). Conclusions: The limited concordance between patient preference and perception and between patient and physician perceptions regarding how the treatment decision was made suggests that physicians should more accurately identify patient preferences by directly asking patients at the beginning of each clinical encounter.

AB - Introduction: This study explores patient preferences for involvement in lung cancer treatment decisions and the extent of concordance between the views of patients and physicians on decisional roles. The impact of demographic and psychosocial characteristics on the decisional role of patients is also examined. Methods: Patients with relapsed non-small cell lung cancer who were candidates for a phase II trial of erlotinib monotherapy were recruited. Patients were interviewed after they had learned of their relapse and the treatment decision had been made but before pharmacologic intervention. Results: Most of the 28 participants were married, had a smoking history, and were well educated. They reported moderate levels of depression and anxiety. Initially, 14% of the patients reported a preference for active decision making; later, 29% believed that the primary responsibility for the treatment decision had been theirs. Only 54% of the patients agreed with the physician's assessment of how the treatment decision was made (κ = 0.31; test of symmetry, p = 0.23). The depression score was significantly associated with a patient's preferred level of control (p <0.01). Conclusions: The limited concordance between patient preference and perception and between patient and physician perceptions regarding how the treatment decision was made suggests that physicians should more accurately identify patient preferences by directly asking patients at the beginning of each clinical encounter.

KW - Decisional role

KW - Non-small cell lung cancer

KW - Perception

KW - Preference

UR - http://www.scopus.com/inward/record.url?scp=77958173998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958173998&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e3181f1c8cb

DO - 10.1097/JTO.0b013e3181f1c8cb

M3 - Article

VL - 5

SP - 1668

EP - 1672

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 10

ER -